您的位置: 首页 > 农业专利 > 详情页

USE OF BMP ANTAGONISTS TO REGULATE HEPCIDIN-MEDIATED IRON METABOLISM
专利权人:
The General Hospital Corporation
发明人:
LIN, Herbert,BABITT, Jodie,CHUNG, Raymond,SAMAD, Tarek,SCHNEYER, Alan,WOOLF, Clifford
申请号:
HK16106934.8
公开号:
HK1218875A
申请日:
2016.06.16
申请国别(地区):
HK
年份:
2017
代理人:
摘要:
The present invention provides new systems and strategies for the regulation of iron metabolism in mammals. In particular, methods of using agonists and antagonists of TGF-² superfamily members to modulate the expression or activity of hepcidin, a key regulator of iron metabolism, are described. The inventive methods find applications in the treatment of diseases associated with iron overload, such as juvenile hemochromatosis and adult hemochromatosis, and in the treatment of diseases associated with iron deficiency, such as anemia of chronic disease and EPO resistant anemia in end-stage of renal disease. The present invention also relates to screening tools and methods for the development of novel drugs and therapies for treating iron metabolism disorders.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充